Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
about
Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Pembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility.PDL-1 blockade prevents T cell exhaustion, inhibits autophagy, and promotes clearance of Leishmania donovani.Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic Trypanosoma cruzi Infection.Not All Immune Checkpoints Are Created EqualStructure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
P2860
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@en
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@nl
type
label
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@en
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@nl
prefLabel
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@en
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@nl
P2093
P2860
P1476
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.
@en
P2093
Eunseon Ahn
Haydn T Kissick
Junghwa Lee
Rafi Ahmed
P2860
P356
10.1615/FORUMIMMUNDISTHER.2015014188
P577
2015-01-01T00:00:00Z